Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 1995BloodOpen Access

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

Jorge E. Cortés
Jorge E. CortésAugusta University HealthSOSM O'BrienUniversity of VermontSPSherry PierceThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cortes et al. (1995) studied this question.

synapsesocial.com/papers/69d809e5a2a48916bbbeea81https://doi.org/10.1182/blood.v86.6.2091.bloodjournal8662091
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.1986 · 43 citations
  2. 2Central Nervous System Pharmacology of Antileukemic Drugs1989 · 144 citations
  3. 3Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study1982 · 138 citations